TB-500 + BPC-157 20mg (10+10) Blend

TB-500 + BPC-157 20mg

Concentrated regenerative duo . Extended protocols

99% Purity Regeneration Flagship

High-concentration presentation of the TB-500 + BPC-157 blend (10 mg + 10 mg per vial). Intended for users who require extended cycles, complex injuries or high doses without having to manage multiple vials. Same synergistic profile as the 5+5 version but with double the yield per vial, which makes it more practical for professional recovery protocols or high-volume athletes.

Key Benefits

Higher yield per vial

Ideal for extended cycles

High doses in less volume

Advanced injury recovery

Cost-per-dose optimization

Same therapeutic profile as 5+5

Mechanism of Action

Combines the local action of BPC-157 (upregulation of VEGF/EGF and angiogenesis at the application site) with the systemic tissue remodeling of TB-500 (an actin-regulating fragment of Thymosin Beta-4), covering complementary phases of the connective-tissue repair cascade. The 10+10 concentration maintains the same therapeutic profile as the 5+5 version with double the yield per vial.

Verify Product Contact

Protocol

Reconstitution & Usage Protocol

Important: Only chill the water 3 minutes before reconstituting the peptide. Do not prepare with very cold water, because it can freeze, lose effect or become damaged.

1Reconstitution

Materials: 1 vial TB-500+BPC-157 20 mg (10+10) . 1 vial of bacteriostatic water . U-100 insulin syringe . alcohol wipes.

Bring the vial to room temperature for 15-20 minutes.
Disinfect the rubber caps with an alcohol wipe.
Draw 2 mL of bacteriostatic water (200 IU).
Inject the water slowly along the inner wall of the vial.
Do not shake. Swirl gently until the solution is clear.

Label with the date and refrigerate (2-8 C). Stable for 28 days.

2Concentration & Dosing

Reconstituting 10 mg + 10 mg in 2 mL -> 5 mg/mL of each = 50 mcg of each peptide per IU.

Target dose	Units	Volume
250+250 mcg	5 IU	0.05 mL
500+500 mcg (standard)	10 IU	0.10 mL
750+750 mcg	15 IU	0.15 mL
1000+1000 mcg (high)	20 IU	0.20 mL

Universal formula: IU = (dose in mcg of each peptide / 50)

3Application

Route

Subcutaneous in the abdomen or near the injured area.

Frequency

Once a day or every other day.

Cycle

6-8 weeks with a 4-week break.

Loading phase: daily dose the first week; then 3-4 times/week.
Before applying: let the drawn dose lose its chill (only the amount to be injected) - hold the syringe in your hand for 2-3 minutes.
After applying: gently massage the area for ~40 seconds to disperse the peptide and improve absorption.

Importante: Solo poner a enfriar el agua 3 minutos antes de reconstituir el peptido. No preparar con agua muy fria, porque se puede congelar, perder efecto o danarse.

1Reconstitución

Materiales: 1 vial TB-500+BPC-157 20 mg (10+10) . 1 vial de agua bacteriostatica . jeringa de insulina U-100 . toallitas de alcohol.

Atemperar el vial a temperatura ambiente 15-20 minutos.
Desinfectar las tapas de goma con toallita de alcohol.
Cargar 2 mL de agua bacteriostatica (200 UI).
Inyectar el agua lentamente por la pared interior del vial.
No agitar. Girar suavemente hasta solucion transparente.

Etiquetar con fecha y refrigerar (2-8 C). Estable 28 dias.

2Concentración y dosis

Reconstituyendo 10 mg + 10 mg en 2 mL -> 5 mg/mL de cada uno = 50 mcg de cada peptido por UI.

Dosis objetivo	Unidades	Volumen
250+250 mcg	5 UI	0,05 mL
500+500 mcg (estandar)	10 UI	0,10 mL
750+750 mcg	15 UI	0,15 mL
1000+1000 mcg (alta)	20 UI	0,20 mL

Formula universal: UI = (dosis en mcg de cada peptido / 50)

3Aplicación

Vía

Subcutanea en abdomen o cerca de la zona lesionada.

Frecuencia

1 vez al dia o dia por medio.

Ciclo

6-8 semanas con descanso de 4 semanas.

Fase de carga: dosis diaria primera semana; luego 3-4 veces/semana.
Antes de aplicar: dejar que la dosis cargada pierda el frio (solo la cantidad a inyectar) - sostener la jeringa en la mano 2-3 minutos.
Despues de aplicar: masaje suave en la zona durante ~40 segundos para dispersar el peptido y mejorar absorcion.

Important : Ne mettre l'eau a refroidir que 3 minutes avant de reconstituer le peptide. Ne pas preparer avec de l'eau tres froide, car elle peut geler, perdre son effet ou s'endommager.

1Reconstitution

Materiel : 1 flacon TB-500+BPC-157 20 mg (10+10) . 1 flacon d'eau bacteriostatique . seringue a insuline U-100 . lingettes d'alcool.

Amener le flacon a temperature ambiante pendant 15-20 minutes.
Desinfecter les bouchons en caoutchouc avec une lingette d'alcool.
Prelever 2 mL d'eau bacteriostatique (200 UI).
Injecter l'eau lentement le long de la paroi interieure du flacon.
Ne pas agiter. Faire tourner doucement jusqu'a obtention d'une solution transparente.

Etiqueter avec la date et refrigerer (2-8 C). Stable 28 jours.

2Concentration et dosage

En reconstituant 10 mg + 10 mg dans 2 mL -> 5 mg/mL de chacun = 50 mcg de chaque peptide par UI.

Dose cible	Unités	Volume
250+250 mcg	5 UI	0,05 mL
500+500 mcg (standard)	10 UI	0,10 mL
750+750 mcg	15 UI	0,15 mL
1000+1000 mcg (elevee)	20 UI	0,20 mL

Formule universelle : UI = (dose en mcg de chaque peptide / 50)

3Application

Voie

Sous-cutanee dans l'abdomen ou pres de la zone lesee.

Fréquence

1 fois par jour ou un jour sur deux.

Cycle

6-8 semaines avec une pause de 4 semaines.

Phase de charge : dose quotidienne la premiere semaine ; puis 3-4 fois/semaine.
Avant l'application : laisser la dose prelevee perdre son froid (seulement la quantite a injecter) - tenir la seringue dans la main pendant 2-3 minutes.
Apres l'application : massage doux de la zone pendant ~40 secondes pour disperser le peptide et ameliorer l'absorption.

Open dosage calculator →

Research Highlights

Preclinical models indicate BPC-157 upregulates VEGF and EGF signaling, supporting angiogenesis and accelerated repair localized to the application site.
TB-500, an actin-regulating fragment of Thymosin Beta-4, has been studied for promoting cell migration and systemic tissue remodeling across multiple structures.
The 10+10 mg presentation supports research into extended, high-dose protocols where the two peptides cover complementary local and systemic phases of the connective-tissue repair cascade.

FAQ

Frequently Asked Questions

How does the 20 mg (10+10) version differ from the standard 5+5 blend?

This is the high-concentration presentation of the same pairing, with 10 mg of TB-500 plus 10 mg of BPC-157 per vial instead of 5+5. The peptide ratio and synergistic profile are identical; the difference is double the yield per vial, allowing high doses in a single injection and fewer reconstitutions across long protocols.

How is the 20 mg vial reconstituted and what concentration results?

Reconstitute the 20 mg vial with 2 mL of bacteriostatic water (200 IU), injecting slowly along the inner wall and swirling gently without shaking. This yields 5 mg/mL of each peptide, equal to 50 mcg of each per IU; a 10 IU draw (0.10 mL) delivers the standard 500+500 mcg dose.

What research route, frequency and cycle are typical for this blend?

In documented protocols it is administered subcutaneously in the abdomen or near the area of interest, once a day or every other day. A loading phase uses a daily dose during the first week, then 3-4 times per week, over a 6-8 week cycle followed by a 4-week break.

How should the reconstituted blend be stored and handled?

After reconstitution, label the vial with the date and refrigerate at 2-8 C, where it stays stable for 28 days. Chill the water only 3 minutes before mixing and never use very cold water. Before injecting, let the drawn dose lose its chill by holding the syringe 2-3 minutes; this material is for laboratory research use only.

Related Compounds

← Previous

TB-500 + BPC-157 Blend

IGF-1 LR3

← Back to full catalog